Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Clinical trial NCT00787787 · TERMINATED

Trial details

NCT number: NCT00787787
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2008-09-01
Primary completion: 2010-04-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.